Image: Marko Geber/Getty Photographs
Pfizer and BioNTech have officially requested that their COVID-19 vaccine be cleared for use among young young children.
In a tweet Thursday, Pfizer explained the corporations submitted their request for an emergency use authorization (EUA) for their vaccine to the U.S. Food items and Drug Administration. They are searching for clearance for it to be made use of among young children ages 5 to eleven.
The request for EUA will be evaluated throughout an approaching Vaccines and Related Organic Items Advisory Committee (VRBPAC) assembly on Oct 26.
“We know from our wide practical experience with other pediatric vaccines that young children are not smaller older people, and we will perform a complete analysis of scientific demo facts submitted in assist of the safety and success of the vaccine made use of in a younger pediatric populace, which might will need a distinct dosage or formulation from